Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pipamperone/antipsychotics

Next Previous
Search
Drug Profile

Pipamperone/antipsychotics

Alternative Names: Clozapine/pipamperone; Paliperidone/pipamperone; Pipamperone/clozapine; Pipamperone/paliperidone; Pipamperone/risperidone; PNB-02; Risperidone/pipamperone

Latest Information Update: 22 Sep 2015

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator PharmaNeuroBoost
  • Class Antidepressants; Antipsychotics; Butyrophenones; Isonipecotic acids; Small molecules
  • Mechanism of Action Dopamine D2 receptor antagonists; Dopamine D4 receptor antagonists; Serotonin 5-HT2A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Schizoaffective disorder; Schizophrenia

Highest Development Phases

  • No development reported Schizophrenia

Most Recent Events

  • 22 Sep 2015 No recent reports on development identified - Phase-I/II for Schizophrenia (Combination therapy) in Belgium (PO)
  • 21 Dec 2012 PharmaNeuroBoost completes a phase I/IIa trial in Schizophrenia in Belgium (NCT01450514)
  • 01 Mar 2012 Phase-I/II clinical trials in Schizophrenia in Belgium (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top